-
Non Regulatory November 4, 2025Vivesto receives positive new Cantrixil preclinical results in AML
-
Non Regulatory August 14, 2025First patient dosed in Vivesto’s Paccal Vet dose-finding study in cats
-
Regulatory May 8, 2025Report from Annual General Meeting in Vivesto AB
Interim Report Q2 2025 (in Swedish)
Vivesto published its Q2 report for 2025 on August 12, 2025, at 08.00 am CEST.